Literature DB >> 24532246

Concurrent chemoradiotherapy compared with surgery and adjuvant radiotherapy for oral cavity squamous cell carcinoma.

Sinclair M Gore1, Anthony K Crombie, Martin D Batstone, Jonathan R Clark.   

Abstract

BACKGROUND: The purpose of this study was to compare survival and functional outcomes in patients with advanced oral cavity squamous cell carcinoma (SCC) treated with either surgery + adjuvant radiotherapy (RT) or concurrent chemoradiotherapy (CRT).
METHODS: Patients treated with curative intent by either surgery + RT or concurrent CRT were identified over a 6-year period (2001-2007). Disease and functional outcomes were analyzed on an intention-to-treat basis.
RESULTS: Fifty-four patients underwent surgical excision and received postoperative RT. Fifty patients underwent concurrent CRT. Overall survival (OS) and disease-specific survival (DSS) was significantly higher in the surgically treated group (p < .001). Long-term enteral feeding tube support was more commonly required in those treated with CRT, whereas osteoradionecrosis rates were comparable between the 2 groups.
CONCLUSION: Treatment by surgery + adjuvant RT for advanced oral cavity SCC resulted in better disease control than treatment with CRT. This supports traditional surgical treatment algorithms for oral cavity cancer.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  chemoradiotherapy; feeding tube; head and neck cancer; organ preservation; osteoradionecrosis

Mesh:

Year:  2014        PMID: 24532246     DOI: 10.1002/hed.23626

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  20 in total

1.  Differences in Survival With Surgery and Postoperative Radiotherapy Compared With Definitive Chemoradiotherapy for Oral Cavity Cancer: A National Cancer Database Analysis.

Authors:  Michael T Spiotto; Gina Jefferson; Barry Wenig; Michael Markiewicz; Ralph R Weichselbaum; Matthew Koshy
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-07-01       Impact factor: 6.223

2.  Prognostic value of volumetric FDG PET/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra-arterial chemoradiotherapy.

Authors:  Satoko Suzuki-Shibata; Yayoi Yamamoto; Tetsuo Yoshida; Nobutaka Mizoguchi; Tetsuo Nonaka; Akira Kubota; Hiroto Narimatsu; Yohei Miyagi; Toshiaki Kobayashi; Tomohiro Kaneta; Tomio Inoue
Journal:  Jpn J Radiol       Date:  2017-10-16       Impact factor: 2.374

Review 3.  Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.

Authors:  Steven B Chinn; Jeffrey N Myers
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

4.  Treatment outcome of advance staged oral cavity cancer: concurrent chemoradiotherapy compared with primary surgery.

Authors:  Manupol Tangthongkum; Virat Kirtsreesakul; Pasawat Supanimitjaroenporn; Peesit Leelasawatsuk
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-20       Impact factor: 2.503

5.  Concurrent chemoradiotherapy with S-1 in patients with stage III-IV oral squamous cell carcinoma: A retrospective analysis of nodal classification based on the neck node level.

Authors:  Ryuji Murakami; Akiko Semba; Kenta Kawahara; Keiya Matsuyama; Akimitsu Hiraki; Masashi Nagata; Ryo Toya; Yasuyuki Yamashita; Natsuo Oya; Hideki Nakayama
Journal:  Mol Clin Oncol       Date:  2017-05-29

Review 6.  Contemporary Treatment of Locally Advanced Oral Cancer.

Authors:  David Kim; Ryan Li
Journal:  Curr Treat Options Oncol       Date:  2019-03-14

Review 7.  Induction Chemotherapy for Advanced Oral Cavity Cancer.

Authors:  Thiago Bueno de Oliveira; Gustavo Nader Marta; Gilberto de Castro Junior; Luiz Paulo Kowalski
Journal:  Curr Oncol Rep       Date:  2021-08-27       Impact factor: 5.075

8.  Total or subtotal glossectomy with laryngeal preservation: a national study of 29 patients.

Authors:  Harri Keski-Säntti; Leif Bäck; Patrik Lassus; Petri Koivunen; Ilpo Kinnunen; Henry Blomster; Antti A Mäkitie; Katri Aro
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-08       Impact factor: 2.503

9.  AKIP1 promotes tumor progression by cancer-related pathways and predicts prognosis in tongue squamous cell carcinoma.

Authors:  Ning Wang; Dan Bai; Einar Kristiansen; Ruoyu Deng; Shijun Zhang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 10.  Preoperative Immunotherapy in the Multidisciplinary Management of Oral Cavity Cancer.

Authors:  Ramez Philips; Chihun Han; Brian Swendseid; Joseph Curry; Athanassios Argiris; Adam Luginbuhl; Jennifer Johnson
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.